Concepedia

Hitomi Sakai

HS

4

Publications

146

Citations

4

H-Index

2023

Active since

Affiliations

Showa University(Current)

Hokkaido University Hospital

Japanese Foundation For Cancer Research

Hyogo Prefectural Cancer Center

Kindai University

Hitomi Sakai is an author at Showa University.

Publications per year

2023–2024

4

Publications

4

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)

Jun Masuda, Hitomi Sakai, Junji Tsurutani et al. · Journal for ImmunoTherapy of Cancer · 2023 · 59 citations · Full text

The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition

Mitsuo Terada, Aki Ito, Yuichiro Kikawa et al. · Breast Cancer · 2023 · 53 citations · Full text

Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)

Hiroko Masuda, Yuko Tanabe, Hitomi Sakai et al. · The Breast · 2023 · 18 citations · Full text

A randomized, double-blind, placebo-controlled phase II study of olanzapine-based prophylactic antiemetic therapy for delayed and persistent nausea and vomiting in patients with HER2-positive or HER2-low breast cancer treated with trastuzumab deruxtecan: ERICA study (WJOG14320B)

Hitomi Sakai, Junji Tsurutani, Yukinori Ozaki et al. · Annals of Oncology · 2024 · 16 citations · Full text

Rows per page

1–4 of 4